GlycoMimetics Inc. appointed Patricia Andrews to its board of directors.
Andrews is CEO and director of privately held Boston Biomedical Inc.
GlycoMimetics appoints director
Identifying PPE Suppliers During the Pandemic
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
GlycoMimetics appoints director
- Author Kshitiz Goliya
- Theme Healthcare & Pharmaceuticals
- Author
- Kshitiz Goliya
- Theme
- Healthcare & Pharmaceuticals